Analysts Maintain Bullish Stance on DuPont Despite Major Price Target Revisions

DuPont de Nemours is undergoing a significant reassessment by market analysts following the completion of its electronics business spinoff. In a dramatic move, Deutsche Bank has slashed its price target for the chemical giant from $90 to $46 per share, yet maintains its “Buy” recommendation. This apparent contradiction reflects the complex dynamics of corporate restructuring in the chemicals sector.

Institutional Confidence Amid Structural Changes

Despite the stock’s recent volatility, institutional investors continue to demonstrate support for DuPont’s strategic direction. Management has reinforced this confidence through a substantial share repurchase initiative approved on November 6, 2025. The program features:

• $2 billion allocated for stock buybacks
• Potential to acquire up to 12.2% of outstanding shares
• Clear commitment to returning value to shareholders

However, the investment landscape presents mixed signals. Recent insider transactions involving executive sales in the weeks preceding the restructuring have created contrasting messages about leadership sentiment.

Price Target Adjustments: Technical Recalibration Rather Than Fundamental Shift

The dramatic price target reduction by Deutsche Bank, announced just before the Thanksgiving holiday, represents what market experts describe as a technical adjustment rather than a fundamental downgrade. The bank’s maintained “Buy” rating underscores this distinction.

Should investors sell immediately? Or is it worth buying DuPont de Nemours?

DuPont shares currently trade around $38.78, positioning them substantially below the revised analyst target. This significant recalibration acknowledges that considerable enterprise value has transferred to the newly independent Qnity Electronics, which now trades as a separate entity.

Other financial institutions have followed similar recalibration patterns. RBC Capital Markets concurrently adjusted its outlook, reducing its target from $100 to $48 while sustaining its “Outperform” rating.

Restructured Company Positioned for Future Growth

The apparent downward trajectory of price targets actually masks a positive underlying narrative. With current trading levels around $39 and analyst targets in the mid-$40 range, market researchers identify potential upside of 15-20% for investors.

The transformed DuPont emerges as a more focused enterprise, concentrating on its core competencies in specialty chemicals and industrial applications. Market observers now question whether the restructured company can build momentum toward these revised valuation levels in the post-holiday period, or if spinoff-related volatility will continue to influence price action in the near term.